Rutherford Health - Rutherford Health announces membership plan
RNS Number : 9829H
Rutherford Health PLC
09 December 2020
 

Rutherford Health Plc

Rutherford Health announces pioneering membership plan with direct access to its facilities

London, UK, 09 December 2020: Rutherford Health plc (the "Company" or "Group" or "Rutherford"), which operates a network of advanced cancer centres in the UK, has today announced the public launch of Rutherford Direct, a pioneering new membership scheme that offers access to advanced cancer treatment and care.

Rutherford Direct is available to businesses, families and individuals and is the first healthcare plan in the UK to focus exclusively on comprehensive cancer cover.

Rutherford Direct offers customised membership plans which ensure that those diagnosed with cancer are covered for the cost of treatment across a wide range of conditions and for treatment and care through various independent healthcare providers.

Rutherford Direct has been announced by Rutherford Health, which operates a network of advanced cancer centres in the UK.

Members will have access to Rutherford Health's network of cancer facilities and treatments including high energy proton beam therapy.

Rutherford Direct offers a simple two-tier membership - for individuals and businesses - and has started accepting individual and corporate members. Both membership plans will include a comprehensive cancer pathway, post-treatment medical costs, daily cash allowance, cancer support services and travel and accommodation, all within an affordable monthly cover plan.

Membership plans start at £29 per month. The primary goal for Rutherford Direct is to provide members with assurance that they will receive the treatment they need at the appropriate time. Having access to a network of high-quality treatment options is crucial to providing that sense of assurance and confidence for patients.

Mike Moran, CEO of Rutherford Health, stated: "We are very pleased to be launching this unique membership plan which, most importantly, offers greater choice to people who may find themselves diagnosed with cancer.

"One in two people will get cancer in the UK and over 340 working-age individuals are diagnosed with cancer every day. It's vital we continue to develop greater options for patients who often have to wait too long for treatment and to offer a healthcare plan that gives them reassurance and certainty that they will be taken care of as they deal with their illness."

END

Contacts

Rutherford Health plc                   

Michael Moran, Chief Executive Officer Tel: +44 (0) 16 3381 0661              

Grant Thornton (Corporate Adviser)       Tel: +44 (0) 20 7383 5100              

Colin Aaronson / Jamie Barklem

                               

Media House International          07788 414 856 or 0207 710 0020 

Ramsay Smith    ramsay@mediahouse.co.uk

 

About Rutherford Health plc

Rutherford Health plc is at the vanguard of advancing cancer care. Developing and building a network of oncology centres across the UK known as the Rutherford Cancer Centres, offering a comprehensive range of cancer treatments to patients.

The first centre in Newport, South Wales, was the first in the UK to offer high energy proton therapy. In addition, each centre also offers radiotherapy, chemotherapy, immunotherapy, diagnostic imaging and supportive care services.

As well as the Rutherford Cancer Centre South Wales, Rutherford Health plc (formerly known as Proton Partners International Limited) has opened two further centres - the Rutherford Cancer Centre North East in Northumberland and the Rutherford Cancer Centre Thames Valley in Reading, with proton therapy now available in both. Construction of a fourth site in Liverpool, the Rutherford Cancer Centre North West, is now complete and awaiting fitting out.will open this summer.

Rutherford Health plc has partnered with world-leading healthcare technology providers to equip each centre with the very latest and innovative technology, including IBA, Philips and Elekta.

Rutherford Health plc was founded in 2015 by Mike Moran MBE and UK and international cancer experts, including Professor Edward Karol Sikora, former head of the World Health Organisation's cancer programme.       

About Rutherford Direct.

Rutherford Direct is a product offered by Proton Partners International Ltd., a wholly-owned subsidiary of Rutherford Health plc, About Rutherford Health plc. a holding company of a group committed to providing innovative cancer care of the highest quality.

Rutherford Health Plc operates a network of Rutherford Cancer Centres which offer the latest cancer therapies including proton beam therapy. Its centre in South Wales introduced proton beam therapy to the UK and treated a cancer patient with the pioneering treatment in the UK for the first time last year. There are further centres in Northumberland, Reading and Liverpool.

The combined centres operate a centrally-networked management system which allows patients to be treated at any Rutherford centre after they have been screened.

All centres offer proton beam therapy to medically-insured private patients, self-paying patients and NHS patients where the Rutherford is commissioned to provide these services.

For more information on Rutherford Direct, please visit: https://www.rutherforddirect.com/ 

For more information on the Rutherford Cancer Centres, please visit: http://www.therutherford.com

Follow the Rutherford Cancer Centres on twitter: @therutherford_c

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXTPBRTMTTMBRM ]]>